Market Overview:
The global nilvadipine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of hypertension and other cardiovascular diseases, increasing awareness about the benefits of nilvadipine, and growing demand for generic drugs. However, patent expirations of key marketed products is expected to restrain the growth of this market during the forecast period. Based on type, the global nilvadipine market can be segmented into less than 98%, 98% to 99%, and more than 99%. The less than 98% segment is expected to account for a major share of the global nilvadipine market during the forecast period. This segment is projected to grow at a CAGR of XX% from 2018 to 2030. Based on application,the global nilvadipinemarket can be divided into lower blood pressure, anti angina, and other applications.
Product Definition:
Nilvadipine is a calcium channel blocker used to treat hypertension and angina.
Less than 98%:
Nilvadipine is a calcium channel blocking drug used for the treatment of heart failure and hypertension. It works by relaxing muscles across the blood vessels, allowing more blood flow through to the heart muscle. The drug has been approved in Europe and Japan for over 20 years, however it was only launched in Australia & New Zealand recently (2012).
98% to 99%.:
98% to 99% of the drug is manufactured by a chemical reaction between ethylene and propylene. It's basically an industrial solvent that helps in dissolving almost all types of salts, esters, or amides. The major application area for this product is in manufacturing drugs used for the treatment of heart diseases such as arrhythmias and hypertension.
Application Insights:
On the basis of application, the global nilvadipine market has been segmented into lower blood pressure, anti angina and other. The lower blood pressure segment held a major share in 2017 owing to its high usage as an anti-angina agent. It is also used for the treatment of heart failure and various other cardiovascular diseases such as stroke and heart attack. In addition, it is employed for lowering high blood pressure levels caused due to kidney disease or congestive heart failure.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high adoption of this medication, favorable reimbursement scenario and increasing awareness about cardiovascular diseases prevention. In addition, growing geriatric population and rising incidences of hypertension are expected to fuel the growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase in healthcare expenditure by governments along with a rise in disposable income levels among people living in developing countries such as India and China. Moreover, an increase in consumer awareness regarding treatment options for various heart diseases is also anticipated to drive regional market growth during the estimated time span.
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases: The global prevalence of hypertension is estimated to be around 1.13 billion in 2015 and is projected to reach 1.56 billion by 2025. This will create a large pool of patients who will require treatment, thereby driving the demand for nilvadipine products.
- Rising geriatric population: The number of people aged 60 years or above is expected to exceed 2 billion by 2050, accounting for nearly one-third of the world’s population. This growing geriatric population is more susceptible to developing cardiovascular diseases, which will lead to an increase in the demand for nilvadipine products over the forecast period.
- Technological advancements in drug delivery systems: Drug delivery technologies are evolving rapidly and offer new opportunities for delivering drugs with improved efficacy and safety profiles compared with traditional oral formulations. These technological advancements are likely to benefit nilvadipine manufacturers and drive market growth over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Nilvadipine Market Research Report
By Type
Less than 98%, 98% to 99%., More than 99%
By Application
Lower Blood Pressure, Anti Angina, Other
By Companies
Targetmol, Merck, Cayman Chemical, Tocris Bioscience., ApexBio Technolog, GLR Innovations, Toronto Research Chemicals, TCI, Carbone Scientific, Santa Cruz Biotechnology, Inc., MedChemExpress, 3B Scientific, BOC Sciences, J&K Scientific, Shanghai Myrell Chemical Technology Co., LTD, Chengdu McCash Chemical Co., LTD, Shanghai Aladdin Biochemical Technology Co., LTD
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Nilvadipine Market Report Segments:
The global Nilvadipine market is segmented on the basis of:
Types
Less than 98%, 98% to 99%., More than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lower Blood Pressure, Anti Angina, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Targetmol
- Merck
- Cayman Chemical
- Tocris Bioscience.
- ApexBio Technolog
- GLR Innovations
- Toronto Research Chemicals
- TCI
- Carbone Scientific
- Santa Cruz Biotechnology, Inc.
- MedChemExpress
- 3B Scientific
- BOC Sciences
- J&K Scientific
- Shanghai Myrell Chemical Technology Co., LTD
- Chengdu McCash Chemical Co., LTD
- Shanghai Aladdin Biochemical Technology Co., LTD
Highlights of The Nilvadipine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Less than 98%
- 98% to 99%.
- More than 99%
- By Application:
- Lower Blood Pressure
- Anti Angina
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nilvadipine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nilvadipine is a medication used to treat high blood pressure. It works by relaxing the blood vessels and reducing the amount of blood that flows through them. This can lower your blood pressure significantly.
Some of the major players in the nilvadipine market are Targetmol, Merck, Cayman Chemical, Tocris Bioscience., ApexBio Technolog, GLR Innovations, Toronto Research Chemicals, TCI, Carbone Scientific, Santa Cruz Biotechnology, Inc., MedChemExpress, 3B Scientific, BOC Sciences, J&K Scientific, Shanghai Myrell Chemical Technology Co., LTD, Chengdu McCash Chemical Co., LTD, Shanghai Aladdin Biochemical Technology Co., LTD.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nilvadipine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nilvadipine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nilvadipine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nilvadipine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nilvadipine Market Size & Forecast, 2018-2028
4.5.1 Nilvadipine Market Size and Y-o-Y Growth
4.5.2 Nilvadipine Market Absolute $ Opportunity
Chapter 5 Global Nilvadipine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nilvadipine Market Size Forecast by Type
5.2.1 Less than 98%
5.2.2 98% to 99%.
5.2.3 More than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nilvadipine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nilvadipine Market Size Forecast by Applications
6.2.1 Lower Blood Pressure
6.2.2 Anti Angina
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nilvadipine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nilvadipine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nilvadipine Analysis and Forecast
9.1 Introduction
9.2 North America Nilvadipine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nilvadipine Market Size Forecast by Type
9.6.1 Less than 98%
9.6.2 98% to 99%.
9.6.3 More than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nilvadipine Market Size Forecast by Applications
9.10.1 Lower Blood Pressure
9.10.2 Anti Angina
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nilvadipine Analysis and Forecast
10.1 Introduction
10.2 Europe Nilvadipine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nilvadipine Market Size Forecast by Type
10.6.1 Less than 98%
10.6.2 98% to 99%.
10.6.3 More than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nilvadipine Market Size Forecast by Applications
10.10.1 Lower Blood Pressure
10.10.2 Anti Angina
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nilvadipine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nilvadipine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nilvadipine Market Size Forecast by Type
11.6.1 Less than 98%
11.6.2 98% to 99%.
11.6.3 More than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nilvadipine Market Size Forecast by Applications
11.10.1 Lower Blood Pressure
11.10.2 Anti Angina
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nilvadipine Analysis and Forecast
12.1 Introduction
12.2 Latin America Nilvadipine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nilvadipine Market Size Forecast by Type
12.6.1 Less than 98%
12.6.2 98% to 99%.
12.6.3 More than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nilvadipine Market Size Forecast by Applications
12.10.1 Lower Blood Pressure
12.10.2 Anti Angina
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nilvadipine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nilvadipine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nilvadipine Market Size Forecast by Type
13.6.1 Less than 98%
13.6.2 98% to 99%.
13.6.3 More than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nilvadipine Market Size Forecast by Applications
13.10.1 Lower Blood Pressure
13.10.2 Anti Angina
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nilvadipine Market: Competitive Dashboard
14.2 Global Nilvadipine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Targetmol
14.3.2 Merck
14.3.3 Cayman Chemical
14.3.4 Tocris Bioscience.
14.3.5 ApexBio Technolog
14.3.6 GLR Innovations
14.3.7 Toronto Research Chemicals
14.3.8 TCI
14.3.9 Carbone Scientific
14.3.10 Santa Cruz Biotechnology, Inc.
14.3.11 MedChemExpress
14.3.12 3B Scientific
14.3.13 BOC Sciences
14.3.14 J&K Scientific
14.3.15 Shanghai Myrell Chemical Technology Co., LTD
14.3.16 Chengdu McCash Chemical Co., LTD
14.3.17 Shanghai Aladdin Biochemical Technology Co., LTD
